View all news

Janssen Announces European Commission Authorisation of the First Complete Long-Acting Injectable HIV Treatment in Europe

12/21/2020

Multimedia Files:

View all news
Questions? Please contact us:
1-800-950-5089 investor-relations@its.jnj.com